Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients.
Ajay SheshadriRima SalibaBadar PatelTahreem AhmedLuis C BuenoMuhammad H ArainRohtesh S MehtaUday R PopatChitra M HosingGabriela RondonLara BashouraBurton F DickeyRichard E ChamplinAmin M AlousiPublished in: Bone marrow transplantation (2020)